Granalix
Granalix is a biotech company developing innovative formulations of natural compounds that increase their bioavailability.
Granalix is a business in biotechnology, dietary supplements, food and beverage, pharmaceutical based in Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA), founded in 2013.
Granalix is positioned in biotechnology, dietary supplements, food and beverage, pharmaceutical, a segment that rewards a clear, focused offering.
The business is associated with Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA).
The company is listed at the Private company stage of development.
Recorded headcount: c_00001_00010 employees.
| Sector | Biotechnology, Dietary Supplements, Food and Beverage, Pharmaceutical |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA) |
| Founded | 2013 |
| Employees | c_00001_00010 |
| Stage | Private company |
Website: granalix.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account